{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"Gilead Sciences Announces Updated 2020 Guidance - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"N6qifbT7nG\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gilead-sciences-announces-updated-2020-guidance\/\">Gilead Sciences Announces Updated 2020 Guidance<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/gilead-sciences-announces-updated-2020-guidance\/embed\/#?secret=N6qifbT7nG\" width=\"600\" height=\"338\" title=\"&#8220;Gilead Sciences Announces Updated 2020 Guidance&#8221; &#8212; Market Newsdesk\" data-secret=\"N6qifbT7nG\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Gilead Sciences Announces Updated 2020 Guidance FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211; Gilead Sciences, Inc. (Nasdaq: GILD) today announced the company has revised certain elements of its full year 2020 guidance. Updated Full Year 2020 Guidance (In millions, except percentages and per share amounts) Previously Updated October 28, 2020 Updated January 11, 2021 Product Sales $23,000 &#8211; $23,500 $24,300 &#8211; $24,350 Product Sales excluding Veklury \u00a0 $21,500 &#8211; $21,525 Veklury \u00a0 $2,800 &#8211; $2,825 Non-GAAP \u00a0 \u00a0 Product Gross Margin 86% &#8211; 87% ~ 86.5% R&amp;D Expenses Mid-teens percentage growth \u00a0 ~ 20% growth SG&amp;A Expenses Low double-digit percentage growth \u00a0 ~ 10% growth Operating Income $10,700 &#8211; $11,200 $11,650 &#8211; $11,750 Effective Tax Rate ~ 20% ~ 19.0% &#8211; 19.5% Diluted &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210111005378r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"}